In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

The efficacy of trovafloxacin in treating Bacteroides fragilis and Escherichia coli infections was investigated and compared to the efficacy of combined clindamycin and gentamicin therapy in an experimental model of intra-abdominal abscesses in rats. Rats were treated with different doses of CP-116,...

Полное описание

Библиографические подробности

Опубликовано в::	Antimicrob Agents Chemother
Главные авторы:	Thadepalli, H, Reddy, U, Chuah, S K, Thadepalli, F, Malilay, C, Polzer, R J, Hanna, N, Esfandiari, A, Brown, P, Gollapudi, S
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1997
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163755/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9055997/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.3.583
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!